Dog De – Wormer For Human Cancer:

Success Stories

Fenbendazole and cancer are rapidly resurfacing as a popular topic in the world of health. Fenbendazole, also known as “Fenben,” kills parasites by destabilizing their microtubules, starving pesky worms. Cancer patients hope that Fenben can kill cancer cells the same way.

One study states that the “repurposing of veterinary drugs showing promising results for humans use can result in considerable time and cost reduction required to develop new drugs.” 

Studies have shown that Fenben appears to be tolerated well by humans with no reports of significant side effects. While it is not definitive yet, research shows that Fenben is safe for humans.

Another study revealed that “doses up to 500 mg per person did not result in adverse effects.” The study goes on to state that “single doses up to 2,000 mg per person were reported to cause no adverse effects.”

Patients have successfully treated prostate, colon, colorectal, pancreatic, and non-small cell lung cancers by using dog de-wormer for cancer. 

It is important to note that studies have looked at Mebendazole rather than Fenbendazole for treating cancer in humans. While both are used to kill parasites, Mebendazole is designed for humans. Nevertheless, research suggests that Fenbendazole is the more effective medication for cancer treatment in humans.

Various drugs that are widely used for non-cancer diseases show promise for treating cancer. Repurposing these drugs allows new cancer treatments to be researched and introduced quickly at a lower cost, thereby meeting patient’s needs. 

Several success stories other than Joe Tippens have emerged, providing additional proof that Fenben effectively treats cancer.

Success Stories

Clinical Oncology Case Reports, 2021 detail the following three success stories:

Case #1

A 63-year-old Caucasian male presented to his doctor with flank (back) pain, rapid weight loss, and a fever. An abdominal CT revealed a 3 cm solid left lower-pole renal mass. He underwent surgery with pathology showing a high-grade clear cell Renal Cell Carcinoma (RCC). Several months later, he developed more persistent left flank pain, and scans found a new 5.2 cm left kidney mass. The oncologist began Chemotherapy treatment. A follow-up CT weeks later revealed a new mass in the pancreas. 

Sometime later, a new lesion was found on his pelvis. With intolerable side effects from treatment, doctors discontinued his chemo. A friend who had head and neck cancer suggested he try Fenbendazole. After starting Fenbendazole, MRI scans found near-complete resolution of his renal mass and a decrease in the size of his pancreatic and pelvis masses. Ten months later, imaging revealed no recurrence or metastatic disease. He has continued taking Fenbendazole with no reported side effects.

Case #2

A 72-year-old Caucasian male presented to the emergency room with increasing lower urinary tract symptoms and a urethral lesion. Four years after surgery, he developed a cough. Scans showed lung cancer with enlarged lymph nodes, and a head CT revealed a metastatic brain lesion. 

Chemotherapy treatment demonstrated a near-complete response. However, the patient developed a cancerous lesion of his aorta and opted for Fenbendazole therapy, taking 1-gram orally three days per week, vitamin E – 800 mg daily, curcumin – 600 mg, and CBD oil. Serial CT’s of the past nine months showed a significant decrease in size and complete radiographic response.

Case #3

A 63-year-old Caucasian female presented with increasing urinary tract symptoms and blood in her urine. CT imaging revealed a large bladder mass. She was treated with chemotherapy and concurrent Fenbendazole of 1-gram three times weekly. A follow-up CT showed no evidence of disease, so she remained on surveillance with no evidence of disease.

These three cases demonstrate that Fenbendazole was safely repurposed for treating human malignancies. There is little doubt that there are real benefits to taking Fenbendazole, the dog de-wormer for cancer.   

Skepticism still exists

Treating cancer patients with Fenbendazole has its share of skeptics, and as with any new cancer treatment, the use of the drug is highly scrutinized. Some skeptics believe that the results of a dog de-wormer that can treat cancer are too good to be true. They doubt that a simple de-wormer can succeed when many other potential solutions fail. 

It is essential to keep in mind that research is still in its early stages. It is still unclear which tumor’s Fenbendazole will be able to treat effectively. However, a recent paper published in Nature, suggests that Fenbendazole is relevant and can potentially treat many types of cancer. 

Creative policy actions in the current medical regulatory environment are necessary to unleash the massive potential of drug repurposing for patients.